文献速递慢性肾脏病血液净化与透析肾移植

慢性肾脏病试验中体适能结局指标范围与一致性的系统综述

A Systematic Review of Scope and Consistency of Outcome Measures for Physical Fitness in Chronic Kidney Disease Trials.
PubMed 文献 · Kidney Int Rep · 2021-02-13

该研究系统检索2000至2019年MEDLINE、Embase和Cochrane Library的随机试验,评估成人体适能结局指标的范围与一致性。来自111项试验的数据显示,共使用87种测试/测量评估30种结局指标、报告23种结局,覆盖五个体适能域,报告异质性大且指标定义不一致。作者认为标准化体适能评估有望改善试验结局可比性并增强临床推荐。

要点

  • CKD试验体适能结局指标高度异质,尤以指标定义不一致突出。
  • 神经肌肉体适能报告最多(76%试验),其评估方式多达37种测试/测量。
  • 实验室测量占58%、现场测量占31%、患者报告占11%,标准化有望提升可比性。

核心结论

  • CKD随机试验中体适能结局报告存在很大异质性,结局指标定义尤其不一致。
  • 标准化体适能评估可能改善试验结局的可比性并增强临床推荐。

研究设计与样本

  • 系统综述纳入报告成人体适能结局的随机试验,对象为未需肾脏替代治疗的CKD患者、血液透析或腹膜透析患者及肾移植受者。
  • 检索MEDLINE、Embase和Cochrane Library,时间范围为2000年至2019年。
  • 对结局指标的范围、频率和特征进行分类与分析,共纳入111项试验。

主要发现

  • 111项试验使用87种测试/测量评估30种结局指标,共报告23种结局。
  • 结局归入五个体适能域:神经肌肉体适能(76%试验)、运动能力(64%)、生理-代谢(49%)、身体成分(36%)、心肺体适能(30%)。
  • 神经肌肉体适能由37种测试/测量检查,包括问卷的躯体功能部分(27%)、单次最大重复力量(9%)和握力(9%)。
  • 结局测量方式为实验室测量(占全部试验58%)、现场测量(31%)和患者报告(11%)。
  • 常见评估时间点为12周(30%)、26周(23%)和52周(10%)。

关键数值与推荐

  • 神经肌肉体适能由37种测试/测量评估,为报告最多的体适能域(76%试验)。
  • 问卷躯体功能部分用于27%试验,单次最大重复力量与握力各用于9%试验。
  • 实验室测量占58%试验,现场测量占31%,患者报告占11%。
  • 评估时间点以12周(30%)、26周(23%)和52周(10%)常见。

临床怎么用

  • 解读CKD体适能试验时需注意结局指标定义与测量方式不一致,跨试验比较应谨慎。
  • 临床推荐引用体适能证据时,应结合具体体适能域、测量工具和评估时间点判断适用性。
  • 未来试验设计宜采用标准化体适能评估,以提升结局可比性和临床可转化性。

局限性

  • 检索时间限于2000至2019年,未涵盖此后发表的研究。
  • 纳入对象限于未需肾脏替代治疗的CKD患者、透析患者和肾移植受者,其他CKD人群未涉及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Impaired physical fitness is prevalent in people with chronic kidney disease (CKD), associating with an increased risk of mortality, falls, and hospitalization. A plethora of physical fitness outcomes have been reported in randomized trials. This study aimed to assess the scope and consistency of physical fitness outcomes and outcome measures reported in trials in CKD. METHODS: A systematic review of randomized trials reporting physical fitness outcomes in adults with CKD (not requiring kidney replacement therapy) receiving hemodialysis (HD) or peritoneal dialysis and kidney transplant recipients was conducted. Studies were identified from MEDLINE, Embase, and the Cochrane Library from 2000 to 2019. The scope, frequency, and characteristics of outcome measures were categorized and analyzed. RESULTS: From 111 trials, 87 tests/measurements were used to evaluate 30 outcomes measures that reported on 23 outcomes, categorized into five domains of physical fitness: neuromuscular fitness (reported in 76% of trials), exercise capacity (64%), physiological-metabolic (49%), body composition (36%), and cardiorespiratory fitness (30%). Neuromuscular fitness was examined by 37 tests/measurements including the physical function component of questionnaires (27%), one-repetition maximum (9%), and hand-grip strength (9%). Outcome measures were assessed by lab-based (58% of all trials), field-based (31%), and patient-reported measures (11%), and commonly evaluated at 12 (30%), 26 (23%) and 52 weeks (10%), respectively. CONCLUSION: There is large heterogeneity in the reporting of physical fitness outcomes, with inconsistencies particularly in the definitions of outcome measures. Standardization in the assessment of physical fitness will likely improve the comparability of trial outcomes and enhance clinical recommendations.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Jegatheesan DK, Modderman R, Krishnasamy R, et al. A Systematic Review of Scope and Consistency of Outcome Measures for Physical Fitness in Chronic Kidney Disease Trials. Kidney Int Rep. 2021. PMID: 34013106. doi:10.1016/j.ekir.2021.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。